Daniel A. Castellani, M.d. P.c. - Medicare Mental Health Clinic in Williamsville, NY

Daniel A. Castellani, M.d. P.c. is a medicare enrolled mental health clinic (Psychiatry & Neurology - Neurology) in Williamsville, New York. The current practice location for Daniel A. Castellani, M.d. P.c. is 6245 Sheridan Dr, Suite 216, Williamsville, New York. For appointments, you can reach them via phone at (716) 626-2647. The mailing address for Daniel A. Castellani, M.d. P.c. is 6245 Sheridan Dr, Suite 216, Williamsville, New York and phone number is (716) 626-2647.

Daniel A. Castellani, M.d. P.c. is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1134269962. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (716) 626-2647.

Contact Information

Daniel A. Castellani, M.d. P.c.
6245 Sheridan Dr
Suite 216
Williamsville
NY 14221-4834
(716) 626-2647
Not Available

Mental Health Clinic Profile

Full NameDaniel A. Castellani, M.d. P.c.
SpecialityPsychiatry & Neurology
Location6245 Sheridan Dr, Williamsville, New York
Authorized Official Name and PositionDaniel Armand Castellani (PRESIDENT)
Authorized Official Contact7166262647
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Daniel A. Castellani, M.d. P.c.
6245 Sheridan Dr
Suite 216
Williamsville
NY 14221-4834

Ph: (716) 626-2647
Daniel A. Castellani, M.d. P.c.
6245 Sheridan Dr
Suite 216
Williamsville
NY 14221-4834

Ph: (716) 626-2647

NPI Details:

NPI Number1134269962
Provider Enumeration Date02/08/2007
Last Update Date08/22/2020

Medicare PECOS Information:

Medicare PECOS PAC ID8921280173
Medicare Enrollment IDO20110309000060

News Archive

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected. Nearly one-third of women develop anatomic or symptomatic treatment failure within five years of undergoing sacrocolpopexy for pelvic organ prolapse, according to a study published in the May 15 issue of JAMA.

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.

Malnutrition, inflammation complicate blood cholesterol readings in CKD patients

To understand the health effects of high cholesterol levels, doctors first need to assess malnutrition and inflammation status in their chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Poll: 70% of Americans oppose efforts by insurance companies to deny payment for ER visits

Seventy percent of Americans oppose efforts by insurance companies to deny payment for emergency visits when patients believe they are having medical emergencies, but after examination are diagnosed with non-urgent medical conditions, according to the results of a new poll conducted by Harris Interactive on behalf of the American College of Emergency Physicians.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Daniel A. Castellani, M.d. P.c. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1134269962NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Daniel A. Castellani, M.d. P.c. acts as a billing entity for following providers:
Provider NameDaniel Armand Castellani
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1669459368
PECOS PAC ID: 3375725526
Enrollment ID: I20110309000092

News Archive

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected. Nearly one-third of women develop anatomic or symptomatic treatment failure within five years of undergoing sacrocolpopexy for pelvic organ prolapse, according to a study published in the May 15 issue of JAMA.

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.

Malnutrition, inflammation complicate blood cholesterol readings in CKD patients

To understand the health effects of high cholesterol levels, doctors first need to assess malnutrition and inflammation status in their chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Poll: 70% of Americans oppose efforts by insurance companies to deny payment for ER visits

Seventy percent of Americans oppose efforts by insurance companies to deny payment for emergency visits when patients believe they are having medical emergencies, but after examination are diagnosed with non-urgent medical conditions, according to the results of a new poll conducted by Harris Interactive on behalf of the American College of Emergency Physicians.

Read more Medical News

› Verified 7 days ago

News Archive

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected. Nearly one-third of women develop anatomic or symptomatic treatment failure within five years of undergoing sacrocolpopexy for pelvic organ prolapse, according to a study published in the May 15 issue of JAMA.

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.

Malnutrition, inflammation complicate blood cholesterol readings in CKD patients

To understand the health effects of high cholesterol levels, doctors first need to assess malnutrition and inflammation status in their chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Poll: 70% of Americans oppose efforts by insurance companies to deny payment for ER visits

Seventy percent of Americans oppose efforts by insurance companies to deny payment for emergency visits when patients believe they are having medical emergencies, but after examination are diagnosed with non-urgent medical conditions, according to the results of a new poll conducted by Harris Interactive on behalf of the American College of Emergency Physicians.

Read more News

› Verified 7 days ago

Psychiatry & Neurology in Williamsville, NY

Junaid Hashim Md
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5904 Sheridan Dr, Ste 1, Williamsville, NY 14221
Phone: 716-831-9435    
Avalon Centers, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 346 Harris Hill Rd, Williamsville, NY 14221
Phone: 716-839-0999    Fax: 716-839-2058
Svend Gothgen Md
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4140 Sheridan Drive, Suite 5, Williamsville, NY 14221
Phone: 716-634-2652    Fax: 716-634-2653
Nina Szarafin, Lscw, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8205 Main St Ste 14, Williamsville, NY 14221
Phone: 716-203-1096    
Williamsville Psychiatry, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1825 Maple Rd, Suite 200, Williamsville, NY 14221
Phone: 716-886-5493    
Thriveworks
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1120 Youngs Rd Ste 300, Williamsville, NY 14221
Phone: 855-284-7483    
Kinkel Neurologic Center, Llp
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 5 Limestone Dr, Suite B, Williamsville, NY 14221
Phone: 716-632-9399    Fax: 716-692-4342

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.